|The SMAD9 smad9 (Catalog #MBS9221215) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The SMAD9 smad9 product has the following accession number(s) (GI #13959539) (NCBI Accession #O15198.1) (Uniprot Accession #O15198). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD9 is a receptor-regulated SMAD (R-SMAD).
Cellular Location: Cytoplasm. Nucleus. Note: In the cytoplasm in the absence of ligand Migration to the nucleus when complexed with SMAD4 (By similarity). Tissue Location: Expressed in heart, brain, placenta, lung, skeletal muscle, prostate, testis, ovary and small intestine. Also expressed in fetal brain, lung and kidney. SMAD9 also interacts with the following gene(s): ACVR1, ACVRL1, BMP2, BMP4, BMPR1A, BMPR1B, SMAD4. Atrophy, Cardiovascular Diseases, Heart Defects, Congenital, Heart Diseases, Hypertension, Hypertension, Pulmonary, Infertility, Female, Inflammation, Lung Diseases, Vascular Diseases are some of the diseases may be linked to SMAD9 Antibody (Center) Blocking Peptide. The following patways have been known to be associated with this gene. Brain, Embryonic Tissue, Eye, Heart, Kidney, Liver, Lung, Muscle, Skin, Uterus tissues are correlated with this protein.